Ranbaxy launches Valaciclovir tablets in US – 27th Nov 09
2009 November 27
Ranbaxy launches Valaciclovir tablets in US; Valtrex has annual sales of over $ 2 Bn in US; Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period: PharmAsiaNews
Ranbaxy launches Valaciclovir tablets in US reports CNBC TV18 quoting PharmAsiaNews.com. Valaciclovir is branded as Valtrex by GSK. Valtrex has annual sales of over $ 2 Bn in US. Analysts estimate sales worth 0 m for Ranbaxy during exclusivity period. Ranbaxy has ‘First To File’ status for Valaciclovir.
Also Read : New Mutual Fund Offers
Related posts:
- US Court rules Ranbaxy’s generic valganciclovir does not infringe Roche’s Valcyte patent In a verdict on the patent litigation between Roche Palo Alto and the Daiichi-Ranbaxy...
- impax settles patent litigation with Boehringer Ingelheim impax settles patent litigation with Boehringer Ingelheim for drug Flomax; Impax settlement may mean...
- Ranbaxy Labs Q3FY09 standalone net profit of Rs 186.1 crore Ranbaxy Labs has announced its Q3FY09 results. It has reported standalone net profit of Rs...
- Asian markets were trading weak – 27th Nov 09 Asian markets were trading weak. China’s Shanghai Composite was down 1.08% or 34.37 points at...
- Maytas Infra buzzing in today’s trade -9th Nov 09 Maytas Infra buzzing in today’s trade; up over 7%; company got Pune-Sholapur road contract worth...